13 Stock Market News for "CYTK"

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pyxus International, ChinaCache International Holdings, and Zuora and Encourages Investors to Contact the Firm

NEW YORK, July 16, 2019 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pyxus International, Inc., ChinaCache International Holding Ltd., and Zuora, Inc. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be fou... »

SL Account Management Team Assisting Graduate Students With Student Debt

Irvine, July 15, 2019 (GLOBE NEWSWIRE) — When it comes to student loans, anyone who has had one knows how stressful they can be. Many post-secondary graduates want a break from discipline and to experience some freedom before they commit to a career, and others have trouble finding work in their perspective fields. Although not everyone starts earning an income right after graduation, most o... »

Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

SOUTH SAN FRANCISCO, Calif., July 15, 2019 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the completion of patient enrollment in GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 event driven cardiovascular outcomes clinical trial of omecamtiv mecarbil which is being conducted by Amg... »

APRIL: Opening of the Andromeda Investissements simplified public tender offer of APRIL shares at €21.60 per share

From Thursday 11 July until Friday 26 July inclusive, the APRIL shareholders may tender their shares to the simplified public tender offer (“OPAS” or “Offer”) initiated by Andromeda Investissements. The French Financial Markets Authority (“AMF”) declared the Offer compliant as at 9 July 2019 and affixed its visa on the same day to the offer document of Andr... »

Acreage Holdings Appoints Rhonda Kratz as General Manager In the State of Florida, Provides Operation Updates in the Sunshine State And Discloses Departure of Chief Marketing Officer

NEW YORK, July 09, 2019 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0ZV) today announced the appointment of Rhonda Kratz as General Manager in the State of Florida, an incremental operation updates subsequent to Acreage’s first quarter earnings call and also disclosed the departure of Acreage’s Chief Marketing Officer.“We are excited to welcome Rh... »

Associa McKay Management Volunteers at SEC Baseball Tournament

Birmingham, AL, June 18, 2019 (GLOBE NEWSWIRE) — Associa McKay Management recently partnered with McDowell Security and volunteered to collect tickets and direct attendees at the SEC Baseball Tournament at the Hoover Metropolitan Stadium in Hoover, Alabama. McDowell Security donated their proceeds to Associa’s national non-profit organization, Associa Cares. The SEC Baseball Tournament featu... »

60 Biggest Movers From Yesterday

Gainers Sothebys (NYSE: BID) shares climbed 58.6% to close at $56.13 on Monday after the company announced it will be acquired by BidFair for $57 per share in cash. Array BioPharma Inc. (NASDAQ: ARRY) shares surged 56.9% to close at $46.44 after Pfizer Inc. (NYSE: PFE) announced plans to acquire Array BioPharma for $48 per share in cash. UP Fintech Holding Limited (NASDAQ: TIGR) rose 34.8% to clos... »

NCLA Asks Fifth Circuit Court of Appeals to Put an End to Unconstitutional SEC Hearings

Washington, DC, June 11, 2019 (GLOBE NEWSWIRE) — The New Civil Liberties Alliance today filed a brief with the U.S. Court of Appeals for the Fifth Circuit asking to reverse the district court’s decision to dismiss the case of NCLA’s client, Michelle Cochran, for lack of subject-matter jurisdiction. The U.S. Securities & Exchange Commission is trying to force Ms. Cochran,... »

Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS

SOUTH SAN FRANCISCO, Calif. and WASHINGTON, May 30, 2019 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) and The ALS Association today announced the continuation of their partnership in the fight against ALS. Cytokinetics is renewing its Gold Level Sponsorship of the National Walks to Defeat ALS® and Premier Level National ALS Advocacy Conference Sponsorship as well as Platinum L... »

ATTO Announces macOS® Driver Support for 10/25/40/50/100GbE NICs

AMHERST, N.Y., May 29, 2019 (GLOBE NEWSWIRE) — ATTO Technology, Inc., a global leader of storage, network connectivity and infrastructure solutions for data-intensive computing environments, has announced macOS® driver support for the latest generation of ATTO FastFrame™ 3 10/25/40/50/100Gb Ethernet network adapters. The new ATTO FastFrame 3 driver is the industry’s first macOS driver to sup... »

50 Biggest Movers From Friday

Gainers Outlook Therapeutics, Inc. (NASDAQ: OTLK) shares gained 42.4 percent to close at $2.79 on Friday. Avianca Holdings S.A. (NYSE: AVH) shares climbed 28.6 percent to close at $3.96. Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) shares jumped 21.4 percent to close at $0.7630 on Friday. Roth Capital assumed Cyclacel Pharmaceuticals with a Buy rating and a price target of $8. Immunic, Inc. (NASD... »

Global Aesthetic Medicine Market To Reach USD 24.00 Billion By 2026 | Reports And Data

Growing Acceptance of minimally invasive & non-invasive treatment is a significant factor estimated to stimulate market growth. Aesthetic Medicine Market Size – USD 11.32 billion in 2018, Aesthetic Medicine Market Growth – CAGR of 9.7%, Aesthetic Medicine Market Trends – Increasing adoption among men along with millennial and people of the younger generation. NEW YORK, May 07, 2019 (GLOB... »

Cytokinetics Announces Results of FORTITUDE-ALS, a Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS, Presented at American Academy of Neurology Annual Meeting

Trial Did Not Meet Statistical Significance for Primary Efficacy Analysis Patients on All Doses of Reldesemtiv Declined Less Than Patients on Placebo for SVC and ALSFRS-R, With Clinically Meaningful Differences Emerging Over Time Early Terminations and Serious Adverse Events Were Balanced Across Treatment Arms Investor Event & Conference Call on May 6, 2019 at 7:30 a.m. Eastern Time SOUTH SAN ... »